Profile for European Patent Office Patent: 1300396
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Netherlands | C300565 | ⤷ Start Trial |
| Netherlands | C300566 | ⤷ Start Trial |
| Denmark | CA 2012 00052 | ⤷ Start Trial |
| Luxembourg | 92113 | ⤷ Start Trial |
| Ireland | 2012/049 | ⤷ Start Trial |
| France | 12C0074 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1300396
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
